Assessing the validity and feasibility of using a best-worst scaling measure for values elicitation among older adults with newly-diagnosed blood cancers to inform treatment decisions.

Authors

Daniel Richardson

Daniel R. Richardson

The University of North Carolina at Chapel Hill, Chapel Hill, NC

Carl J Mhina, Matthew F. Washko, Allison Mary Deal, Amy C. Cole, Elizabeth C Kwong, Karthik Adapa, Norah L Crossnohere, John F.P. Bridges, Stephanie B. Wheeler, Thomas William LeBlanc, Antonia V. Bennett, Daniel R. Richardson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship

Sub Track

Integrating Patient Experience Assessment and Patient Reported Outcomes Into Practice

Citation

JCO Oncol Pract 19, 2023 (suppl 11; abstr 344)

DOI

10.1200/OP.2023.19.11_suppl.344

Abstract #

344

Poster Bd #

F1

Abstract Disclosures

Similar Posters

Poster

2015 Gastrointestinal Cancers Symposium

Impact of CGA in therapeutic decisions: ELDERLY trial.

Impact of CGA in therapeutic decisions: ELDERLY trial.

First Author: Javier Gallego Plazas

First Author: Andrew Gahagan